Targeting K–ATP channel in diabetic nephropathy: opening or closing?

To the Editor: The effects of oral antidiabetic agents on diabetic nephropathy have been thought to be due to their ability to control blood glucose levels, and few studies have examined whether these agents may also have direct effects on the kidney.